Navigation Links
GENova appoints Dr. Wang Chong to Scientific Advisory Board
Date:9/14/2009

NEW YORK, NY, Sept. 14 /PRNewswire-FirstCall/ - (OTCBB: GVBP.OB) - GENova Biotheropeutics, Inc., ("GENova"), a biotechnology company that develops novel therapeutic proteins that disrupt the advance of life-threatening diseases, today announced it has appointed Dr. Wang Chong to its Scientific Advisory Board.

Dr. Wang Chong will contribute his considerable expertise to the company as it pursues its mandate to develop, patent and commercialize ground-breaking cancer-fighting biotechnologies, with a focus on breast and prostate cancer.

Aaron Whiteman, CEO of GENova stated, "GENova is proud to have attracted such an esteemed me member of the healthcare industry to assist us in our growth plans."

About Dr. Wang Chong

Dr. Wang Chong is a physician with over 19 years of experience in the healthcare industry, whose expertise lies in raising capital for and listing small to medium-sized companies. Previous positions include CFO and Commercial Director of Phytopharm plc, CEO of Osmetech plc, Life Sciences Analyst at Canaccord Capital (Europe) Ltd, Leader of UK Healthcare Initiatives at premier management consultants Arthur D. Little Inc, and commercial roles at Glaxo Wellcome plc and SmithKline Beecham plc. Chong graduated with a medical degree from King's College London and a MBA from London Business School. He is also a Council Member of the Royal Society of Medicine's Pharmaceutical Medicine Research Section and an Associate of the Securities and Investment Institute.

About GENova Biotherapeutics Inc.

GENova is positioning itself as the world's leading bioscience company in the development and commercial licensing of novel therapeutic proteins that disrupt the advance of life-threatening cancers. The company leverages cutting-edge research collaborations to achieve breakthroughs in anti-cancer treatments, and then licenses these patented drug product candidates to Big Pharmaceutical and Biotechnology companies such as Pfizer, Amgen, Myriad Genetics, Medarex, and Biogen Idec. Visit GENova online at www.genovabio.com.

Forward Looking Statements

This document includes certain statements that may be deemed to be "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact, are expected by the Company to be forward-looking statements. Although GENova believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in the forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include but are not limited to the success of the owned intellectual property, the strength of the patents, continued availability of capital and financing, and general economic market or business conditions.


'/>"/>
SOURCE GENova Biotherapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. GENova appoints Dr. Philip Gould to Scientific Advisory Board
2. GENova issues clarifying press release
3. GENova to acquire three new drug target patents worth in excess of $1 billion in royalty fees
4. GENova files patent for new breast cancer treatment
5. GENova appoints Director of Asian business development
6. GENova discusses development of new anti-cancer biotechs potentially worth $400 Million per annum
7. GENova appoints Dr. Anders Boegh Jensen to Scientific Advisory Board
8. Genova files patent for new prostate cancer treatment
9. GENova names Dr. John Savin as Vice President
10. GENova names Aaron Whiteman as CEO
11. InteKrin Therapeutics Appoints Linda Slanec Higgins, PhD Chief Operating Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association (PHA) ... will receive two significant new grants to support its work to advance research ... anniversary by recognizing patients, medical professionals and scientists for their work in fighting ...
(Date:6/24/2016)... San Francisco, CA (PRWEB) , ... June 24, ... ... at CitiDent, is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has ... , self-ligating Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , ...
(Date:6/24/2016)... ... 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ... raise to $12 an hour by 2020 and then adjusting it yearly to increase at ... the minimum wage, assure the wage floor does not erode again, and make future increases ...
(Date:6/24/2016)... ... 2016 , ... EB Medicine presented its first-ever “Issue of ... in Ponte Vedra Beach, FL. The awards honor the outstanding work of leading ... and Pediatric Emergency Medicine Practice. , “With this award, we recognize the efforts ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® & Innovative Solutions today ... cultivation and processing operations at its production facility, and opened its first two ... the manufacturer of a complete system of proactive air and surface purification solutions ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... 26, 2016 Story Highlights: ... models within the health care industry is causing providers ... , Deloitte offers a suite of solutions for ... impacting efficient cost optimization: labor resource analysis, revenue cycle ... facilitate better outcomes and better economics ...
(Date:6/24/2016)... N.J. , June 24, 2016  Collagen ... the design, development and manufacturing of collagen and ... regeneration announced today that Bill Messer ... and Marketing to further leverage the growing portfolio ... medical devices. Bill joins the Collagen ...
(Date:6/24/2016)... June 24, 2016   Bay Area Lyme ... Dean Center for Tick Borne Illness , ... Rehabilitation, MIT Hacking Medicine, University of California, Berkeley, ... announced the five finalists of Lyme Innovation ... More than 100 scientists, clinicians, researchers, entrepreneurs, and ...
Breaking Medicine Technology: